NEW YORK (GenomeWeb) – Belgium-based OncoDNA today announced it has reached a distribution agreement with BioSequence, a Spanish personalized cancer genomics firm.

Under the terms of the agreement, BioSequence will become the exclusive Spanish distributor of OncoDNA's clinical oncology molecular diagnostics. OncoDNA offers OncoDeep Dx, which links specific genes to targeted cancer treatments, as well as other clinical cancer panels to measure translocations and protein presence and activity.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.